Spots Global Cancer Trial Database for cancer of lung
Every month we try and update this database with for cancer of lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung | NCT03603652 | Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Carcinoma, Non-... Non-Small Cell ... Non-Small-Cell ... | Microwave Ablat... | 18 Years - | Ethicon, Inc. | |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer | NCT02410603 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| A Phase I Study of iPS Cell Generation From Patients With COPD | NCT01860898 | Thoracic Diseas... Respiratory Tra... Cancer of Lung Cancer of the L... Lung Cancer Lung Diseases, ... COPD Pulmonary Emphy... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Carcinoma, Smal... | Skin Biopsy | 18 Years - | Mayo Clinic | |
| Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma | NCT02549638 | Carcinoma, Squa... Carcinoma, Squa... Squamous Cell C... Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | DNA Extraction | 18 Years - | Mayo Clinic | |
| 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients | NCT04717804 | Cancer of Lung | AIP CT FB (Free-Breath... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Effect of 3D-printed Reconstruction System in Size of Left DLT | NCT06258954 | Cancer of Lung Lung Isolation | 3D reconstructi... traditional met... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System | NCT02370303 | Lung Cancer Lung Neoplasms Cancer of Lung Cancer of the L... Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Carcinoma, Non-... Adenocarcinoma Squamous Cell C... | 18 Years - | Mayo Clinic | ||
| Real-time Motion Management During Prostate and Lung Radiotherapy | NCT05844761 | Cancer of Lung Lung Metastasis Cancer of Prost... | Triggered imagi... Synchrony MLC t... Synchrony MLC t... | 18 Years - | Region Skane | |
| LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | NCT00328588 | Lung Cancer Cancer of Lung Cancer of the L... Non-Small Cell ... Carcinoma, Non-... | YM155 | 18 Years - | Astellas Pharma Inc | |
| Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma | NCT04300244 | Cancer Cancer, Lung Cancer of Lung Mesothelioma Mesothelioma; L... Mesothelioma; P... Mesotheliomas P... | UV1 vaccine + l... ipilimumab nivolumab | 18 Years - | Oslo University Hospital | |
| Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
| An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors | NCT02616211 | Adenocarcinoma ... Lung Neoplasm Cancer of Lung Lung Cancer Pulmonary Cance... EGFR Genes ALK Genes | 18 Years - | Mayo Clinic | ||
| Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | NCT05132075 | Non-Small Cell ... | JDQ443 docetaxel | 18 Years - | Novartis | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Study of Arsenic Trioxide in Small Cell Lung Cancer | NCT01470248 | Lung Cancer Cancer of Lung Pulmonary Cance... Pulmonary Neopl... Carcinoma, Smal... | Arsenic Trioxid... | 18 Years - | Emory University | |
| Real-time Motion Management During Prostate and Lung Radiotherapy | NCT05844761 | Cancer of Lung Lung Metastasis Cancer of Prost... | Triggered imagi... Synchrony MLC t... Synchrony MLC t... | 18 Years - | Region Skane | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM) | NCT04263467 | Cancer Cancer of Lung | Exercise interv... Standard oncolo... | 18 Years - | Herlev Hospital | |
| 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients | NCT04717804 | Cancer of Lung | AIP CT FB (Free-Breath... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients | NCT04717804 | Cancer of Lung | AIP CT FB (Free-Breath... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung | NCT02853188 | Cancer of Lung | venous thromboe... | 18 Years - | Hopital Foch | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Changing Over Time of Ascorbic Acid After Chemotherapy | NCT02931942 | Leukemia (Both ... Cancer of Lung Myeloma | blood withdrawn | 18 Years - | Maastricht University Medical Center | |
| Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer | NCT05132075 | Non-Small Cell ... | JDQ443 docetaxel | 18 Years - | Novartis | |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy | NCT03102229 | Cancer of the H... Cancer of Lung Cancer of Esoph... Cancer of Stoma... | Enhanced Suppor... Enhanced Suppor... | 18 Years - | Albert Einstein College of Medicine | |
| MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) | NCT02673021 | Lung Neoplasms Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... Metastatic Canc... | Microwave ablat... | 18 Years - | Mayo Clinic | |
| Breath Test for Early Detection of Lung Cancer | NCT00639067 | Lung Neoplasms | Breath Collecti... | 18 Years - | Menssana Research, Inc. | |
| Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma | NCT04300244 | Cancer Cancer, Lung Cancer of Lung Mesothelioma Mesothelioma; L... Mesothelioma; P... Mesotheliomas P... | UV1 vaccine + l... ipilimumab nivolumab | 18 Years - | Oslo University Hospital | |
| Changing Over Time of Ascorbic Acid After Chemotherapy | NCT02931942 | Leukemia (Both ... Cancer of Lung Myeloma | blood withdrawn | 18 Years - | Maastricht University Medical Center | |
| Real-time Activity Monitoring to Prevent Admissions During RadioTherapy | NCT03102229 | Cancer of the H... Cancer of Lung Cancer of Esoph... Cancer of Stoma... | Enhanced Suppor... Enhanced Suppor... | 18 Years - | Albert Einstein College of Medicine | |
| 4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients | NCT04717804 | Cancer of Lung | AIP CT FB (Free-Breath... | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation | NCT04699188 | KRAS G12C Mutan... Carcinoma, Non-... Carcinoma, Colo... Cancer of Lung Cancer of the L... Lung Cancer Neoplasms, Lung Neoplasms, Pulm... Pulmonary Cance... Pulmonary Neopl... | JDQ443 TNO155 tislelizumab | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
